ABSTRACT
Introduction:
Vitamin D deficiency increases gingivitis risk. Studies show that higher vitamin D levels reduce inflammation.
Materials and Methods:
College conducted a double-blind, randomized, controlled trial on 451 people’s vitamin D and gingival health at baseline. For three months, participants were given a placebo (group A), 1000 international units (IU) of vitamin D3 per day (group B), 500 IU per day (group C), or 2000 IU per day (group A). Gingival scores were recorded for three months to assess the anti-inflammatory effect (the first, second, and third). Vitamin D levels also affected gingivitis.
Results:
Vitamin D dose-dependently reduces gingivitis inflammation. Vitamin D administration negatively correlated with gingival index score. Anti-inflammatory vitamin D levels are 32–37 ng/ml.
Conclusion:
Vitamin D supplementation can reduce gingivitis severity. The optimal blood vitamin D level is 30–35 ng/ml.
KEYWORDS: Anti-inflammatory, gingivits, vitamin D
INTRODUCTION
Gingivitis the mildest periodontal disease affects half the globe. Inflammation redness, swelling, bleeding, and pus are more prevalent than discomfort in diagnosing gingivitis.[1] Everyone is affected. Wealthy countries have witnessed a decade-long gingivitis reduction. Gingivitis varies by geography.[2] Gingivitis bleeding gums close to at least one tooth affects over half of Americans, with men, blacks, and Mexican Americans having greater rates than whites.[3] Early lesions accelerate disease.[4] Bacterial plaque at the gingival margin causes gingivitis, although diet may contribute. Vitamin deficits caused gingivitis.[5]
Gingivitis needs plaque removal. Therapy kills most mouth germs. Self-care and frequent professional cleanings may do this.[6] Scaling, root planning, and curettage treat clinical gingivitis. Flossing and chlorhexidine or hydrogen peroxide mouthwashes may cure gingivitis.[7] Vitamin D pills cure gingivitis affordably and safely.[8]
Vitamin D may decrease gingival inflammation, according to NHANES III cross-sectional data. Those with the highest 25(OH) D levels had 20% less bleeding on probing than those with the lowest levels.[9] Clinical attachment level (CAL) inversely linked with 25(OH) D levels in over-50s.[10] Vitamin D is necessary but secondary. Treating the aforementioned may cure vitamin D deficiency.[11] Vitamin D levels may rise from 50 to 80 nmol/L with 1700 IU daily. Supplement recommendations prioritize safety.[12,13] This research studied vitamin D’s dosage-dependent gingivitis-fighting properties. To minimize gingivitis inflammation, we must establish the serum vitamin D level that correlates with gum health following oral vitamin D consumption.
MATERIALS AND METHODS
IRB 02/IEC/RDCHRC/2022/039 accepted Rama Dental College’s research. This randomized, double-blind, placebo-controlled trial assessed vitamin D’s anti-inflammatory benefits. This two-year research screened from June to October 2022. Participants were recalled on vitamin D oral consumption days 30, 60, and 90. Each follow-up included clinical gingivitis and biochemical vitamin D and calcium assays. All applicants will have periodontal pockets under 3 millimeters. Loe and Sillness gingivitis index-1963 gingivitis >1. 20-65 ng/mL serum 25-hydroxyvitamin D patients were selected.
Missing teeth, severe periodontal disease with active bleeding gums, poorly damaged teeth (due to dental caries, cervical abrasion, or enamel loss), severely fractured teeth, or temporary fillings are not considered. No orthodontics were hired. Dental prophylaxis or procedures within a month were omitted. Side-effect-prone vitamin D pill users.
Clinical assessment of gingivitis for the study assessed gingiva inflammation using Loe and Silness index criteria and blood vitamin D and/or calcium levels at week 0 and week 12.
Intervention: Groups A–D got 2000, 1000, 500, and a placebo, respectively. Vitamin D kits comprising 30 pills of 2000 IU, 1000 IU, 500 IU, and placebo were randomly distributed. Vitamin D pills were taken regularly.
RESULTS
In Table 1, we can see how old the study participants were at the start, how old they were at the conclusion, and how many of them dropped out.
Table 1.
Distribution of study subjects by study groups
Study subject groups | Group A | Group B | Group C | Group D |
---|---|---|---|---|
Subjects at the start of the study | 24 | 24 | 24 | 24 |
Subjects at the end of the study | 22 | 22 | 22 | 22 |
Male | 13 | 13 | 14 | 14 |
Female | 11 | 11 | 10 | 10 |
No of Dropouts | 2 | 2 | 2 | 2 |
Mean age | 30.56 | 30.23 | 30.66 | 30.45 |
SD | 10.34 | 9.44 | 8.34 | 9.45 |
Vitamin D baseline: 9.91% monthly increases. Following one month, gingival scores declined from 2.4 to 1.7, 0.8, and 0.3 after three months. A Wilcoxon paired test comparing baseline values to future scores indicated group A had a statistically significant anti-inflammatory impact after one month. Group B’s vitamin D increased 5.62 per month from 26.50 + 3.68 to 43.67 + 8.80. 2.3 gingival scores began this group. One month, 2.0, two months, 1.1, and three months, 0.5. After two months, this group demonstrated strong anti-inflammatory benefits. After three months, group C’s gingival scores reduced from 2.2 to 1.9, 1.4 to 0.8, and 0.8 to 0.2, showing an anti-inflammatory effect (P = 0.0001). Vitamin D rose 4.27 per month from 23.98 + 5.65 to 36.8 + 1 + 6.13 [Table 2].
Table 2.
Summary statistics of the levels
Group | Variable | Follow-ups | Mean | Standard deviation | Standard error |
---|---|---|---|---|---|
A | Serum vitamin D | Baseline | 22.47 | 6.98 | 1.49 |
Final visit | 52.2 | 10.18 | 2.17 | ||
Serum calcium | Baseline | 9.66 | 0.28 | 0.06 | |
2 visit | 9.75 | 0.24 | 0.05 | ||
3 visit | 9.91 | 0.21 | 0.04 | ||
Final visit | 9.99 | 0.26 | 0.05 | ||
Gingival score | Baseline | 2.41 | 0.54 | 0.12 | |
2 visit | 1.78 | 0.63 | 0.13 | ||
3 visit | 0.9 | 0.74 | 0.16 | ||
Final visit | 0.34 | 0.6 | 0.13 | ||
B | Serum vitamin D | Baseline | 26.80 | 3.68 | 0.78 |
Final visit | 43.67 | 8.80 | 1.87 | ||
Serum calcium | Baseline | 9.61 | 0.34 | 0.07 | |
2 visit | 9.64 | 0.30 | 0.06 | ||
3 visit | 9.79 | 0.31 | 0.06 | ||
Final visit | 9.94 | 0.39 | 0.08 | ||
Gingival score | Baseline | 2.39 | 0.57 | 0.12 | |
2 visit | 2.01 | 0.58 | 0.12 | ||
3 visit | 1.16 | 0.71 | 0.15 | ||
Final visit | 0.55 | 0.66 | 0.14 | ||
C | Serum vitamin D | Baseline | 23.98 | 5.05 | 1.07 |
Final visit | 36.81 | 6.13 | 1.30 | ||
Serum calcium | Baseline | 9.60 | 0.42 | 0.09 | |
2 visit | 9.56 | 0.42 | 0.09 | ||
3 visit | 9.74 | 0.25 | 0.05 | ||
Final visit | 9.80 | 0.35 | 0.07 | ||
Gingival score | Baseline | 2.24 | 0.46 | 0.09 | |
2 visit | 1.96 | 0.46 | 0.09 | ||
3 visit | 1.43 | 0.75 | 0.16 | ||
Final visit | 0.88 | 0.98 | 0.21 | ||
D | Serum vitamin D | Baseline | 28.18 | 3.07 | 0.65 |
Final visit | 28.52 | 4.04 | 0.86 | ||
Serum calcium | Baseline | 9.86 | 0.40 | 0.08 | |
2 visit | 9.71 | 0.40 | 0.08 | ||
3 visit | 9.83 | 0.45 | 0.09 | ||
Final visit | 9.92 | 0.48 | 0.10 | ||
Gingival score | Baseline | 2.23 | 0.61 | 0.13 | |
2 visit | 1.96 | 0.63 | 0.13 | ||
3 visit | 1.90 | 0.67 | 0.14 | ||
Final visit | 1.89 | 0.64 | 0.13 |
DISCUSSION
Dental hygiene requires mouthwash.[7] Vitamin D levels increased in all groups after taking tablets.[14] Oral vitamin D improved linearly, according to Heaney, Davies, Chen, and colleagues (2003).[15] Earlier research had similar findings. Vitamin D reduces inflammation in vitro. Vitamin D reduces antigen-triggered T-cell proliferation and cytokine production, specifically interleukin-2 and interferon.[16,17]
Consequently, 500–2000 I.U. U/day oral vitamin D intake reduces inflammation. 500 I.U. induces anti-inflammation. Further research: Anti-inflammatory vitamin D requires 500 IU daily.[18] Inanir A, Ozoran K, Tutkak H, and Mermerci B (2004) observed that patients administered calcitriol for six months had substantially greater BMD and lower blood IL-1 and TNF-alpha than those given calcium alone.[18]
CONCLUSION
Vitamin D’s anti-inflammatory effects are most noticeable around 2,000 IU, but there is no safe or effective maximum dose. At 30–35 ng/ml, oral vitamin D supplementation protects against gingivitis’ inflammatory process. This range was best for this effect.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.Ciancio SG. Current status of indices of gingivitis. J Clin Periodontol. 1986;13:375–8. doi: 10.1111/j.1600-051x.1986.tb01476.x. [DOI] [PubMed] [Google Scholar]
- 2.Stamm JW. Epidemiology of gingivitis. J Clin Periodontol. 1986;13:360–6. doi: 10.1111/j.1600-051x.1986.tb01473.x. [DOI] [PubMed] [Google Scholar]
- 3.Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States, 1988-1991:Prevalence, extent, and demographic variation. J Dent Res. 1996;75:672–83. doi: 10.1177/002203459607502S07. [DOI] [PubMed] [Google Scholar]
- 4.Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1–6. doi: 10.1902/annals.1999.4.1.1. [DOI] [PubMed] [Google Scholar]
- 5.Nishida M, Grossi SG, Dunford RG, Ho AW, Trevisan M, Genco RJ. Diet and vitamin C and risk of periodontal diseases. J Periodontol. 2000;71:1215–23. doi: 10.1902/jop.2000.71.8.1215. [DOI] [PubMed] [Google Scholar]
- 6.Volker JF. The relation of nutrition to periodontal disease. J Dent Res. 1962;41:264–78. doi: 10.1177/00220345620410012801. [DOI] [PubMed] [Google Scholar]
- 7.Hasturk H, Nunn M, Warbington M, Van Dyke TE. Efficacy of a fluoridated hydrogen peroxide-based mouthrinse for the treatment of gingivitis:A randomized clinical trial. J Periodontol. 2004;75:57–65. doi: 10.1902/jop.2004.75.1.57. [DOI] [PubMed] [Google Scholar]
- 8.Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health:A review. Altern Med Rev. 2005;10:94–111. [PubMed] [Google Scholar]
- 9.Dietrich T, Nunn M, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentration of 25-hydroxyvitamin D and gingival inflammation. Am J Clin Nutr. 2005;82:575–80. doi: 10.1093/ajcn.82.3.575. [DOI] [PubMed] [Google Scholar]
- 10.Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr. 2004;80:108–13. doi: 10.1093/ajcn/80.1.108. [DOI] [PubMed] [Google Scholar]
- 11.Marriott BM. Vitamin D supplementation:A word of caution. Ann Intern Med. 1997;127:231–3. doi: 10.7326/0003-4819-127-3-199708010-00009. [DOI] [PubMed] [Google Scholar]
- 12.Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288–94. doi: 10.1093/ajcn/73.2.288. [DOI] [PubMed] [Google Scholar]
- 13.Kang M, Ragan BG, Park J-H. Issues in outcomes research:An overview of randomization techniques for clinical trials. J Athl Train. 2008;2:215–21. doi: 10.4085/1062-6050-43.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ilahi M, Armas LAG, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008;87:688–91. doi: 10.1093/ajcn/87.3.688. [DOI] [PubMed] [Google Scholar]
- 15.Heaney RP. Lessons from nutritional science from vitamin D. Am J Clin Nutr. 1999;69:825–6. doi: 10.1093/ajcn/69.5.825. [DOI] [PubMed] [Google Scholar]
- 16.Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87. doi: 10.2147/JIR.S63898. doi:10.2147/JIR. S63898. PMID:24971027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183:5458–67. doi: 10.4049/jimmunol.0803217. doi:10.4049/jimmunol.0803217. PMID:19843932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Inanir A, Ozoran K, Tutkak H, Mermerci B. The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. J Int Med Res. 2004;32:570–82. doi: 10.1177/147323000403200602. [DOI] [PubMed] [Google Scholar]